These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 17069034)

  • 1. [Value of urinary microsatellite analysis in the diagnosis of renal cancer].
    Fernandez F; Schneider A; Gaub MP; Lindner V; Oudet P; Lang H; Saussine C; Jacqmin D
    Prog Urol; 2006 Sep; 16(4):429-34. PubMed ID: 17069034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of microsatellite analysis in urine sediment for diagnosis of bladder cancer.
    Schneider A; Borgnat S; Lang H; Régine O; Lindner V; Kassem M; Saussine C; Oudet P; Jacqmin D; Gaub MP
    Cancer Res; 2000 Aug; 60(16):4617-22. PubMed ID: 10969815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of preoperative molecular serum analysis in renal cancer.
    Gonzalgo ML; Eisenberger CF; Lee SM; Trock BJ; Marshall FF; Hortopan S; Sidransky D; Schoenberg MP
    Clin Cancer Res; 2002 Jun; 8(6):1878-81. PubMed ID: 12060631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microsatellite analysis of urine sediment versus urine cytology for diagnosing transitional cell tumors of the urinary bladder.
    Fornari D; Steven K; Hansen AB; Vibits H; Jepsen JV; Poulsen AL; Schwartz M; Horn T
    APMIS; 2004 Feb; 112(2):148-52. PubMed ID: 15056232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion analysis of tumor and urinary DNA to detect bladder cancer: urine supernatant versus urine sediment.
    Szarvas T; Kovalszky I; Bedi K; Szendroi A; Majoros A; Riesz P; Füle T; László V; Kiss A; Romics I
    Oncol Rep; 2007 Aug; 18(2):405-9. PubMed ID: 17611663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microsatellite analysis of voided-urine samples for surveillance of low-grade non-muscle-invasive urothelial carcinoma: feasibility and clinical utility in a prospective multicenter study (Cost-Effectiveness of Follow-Up of Urinary Bladder Cancer trial [CEFUB]).
    van der Aa MN; Zwarthoff EC; Steyerberg EW; Boogaard MW; Nijsen Y; van der Keur KA; van Exsel AJ; Kirkels WJ; Bangma C; van der Kwast TH
    Eur Urol; 2009 Mar; 55(3):659-67. PubMed ID: 18501499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microsatellite analysis of allelic imbalance in tumour and blood from patients with prostate cancer.
    Schwarzenbach H; Chun FK; Müller I; Seidel C; Urban K; Erbersdobler A; Huland H; Pantel K; Friedrich MG
    BJU Int; 2008 Jul; 102(2):253-8. PubMed ID: 18336598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concentration and microsatellite status of plasma DNA for monitoring patients with renal carcinoma.
    Perego RA; Corizzato M; Brambilla P; Ferrero S; Bianchi C; Fasoli E; Signorini S; Torsello B; Invernizzi L; Bombelli S; Angeloni V; Pitto M; Battaglia C; Proserpio V; Magni F; Galasso G; Mocarelli P
    Eur J Cancer; 2008 May; 44(7):1039-47. PubMed ID: 18397824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular signature for urothelial carcinoma of the upper urinary tract.
    Ho CL; Tzai TS; Chen JC; Tsai HW; Cheng HL; Eisenberger CF; Chow NH
    J Urol; 2008 Mar; 179(3):1155-9. PubMed ID: 18206169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the performance of microsatellite and methylation urine analysis for predicting the recurrence of urothelial cell carcinoma, and definition of a set of markers by Bayesian network analysis.
    Rouprêt M; Hupertan V; Yates DR; Comperat E; Catto JW; Meuth M; Lackmichi A; Ricci S; Lacave R; Gattegno B; Richard F; Hamdy FC; Cussenot O
    BJU Int; 2008 Jun; 101(11):1448-53. PubMed ID: 18325051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic changes in Slovenian patients with gastric adenocarcinoma evaluated in terms of microsatellite DNA.
    Gazvoda B; Juvan R; Zupanic-Pajnic I; Repse S; Ferlan-Marolt K; Balazic J; Komel R
    Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1082-9. PubMed ID: 17998833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microsatellite analysis of induced sputum DNA in patients with lung cancer in heavy smokers and in healthy subjects.
    Castagnaro A; Marangio E; Verduri A; Chetta A; D'Ippolito R; Del Donno M; Olivieri D; Di Cola G
    Exp Lung Res; 2007 Aug; 33(6):289-301. PubMed ID: 17694439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of microvessel density with microvascular invasion, metastasis and prognosis in renal cell carcinoma.
    Yildiz E; Ayan S; Goze F; Gokce G; Gultekin EY
    BJU Int; 2008 Mar; 101(6):758-64. PubMed ID: 18070177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of loss of heterozygosity and microsatellite instability RAD52, RAD54 and RAD54B gene and BRCA1 gene mutation in breast cancer].
    Romanowicz-Makowska H; Smolarz B
    Pol Merkur Lekarski; 2006 Dec; 21(126):548-50. PubMed ID: 17405295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Loss of heterozygosity analysis of microsatellites on multiple chromosome regions in dysplasia and squamous cell carcinoma of esophagus].
    Liu M; Zeng HC; Zhang XL; Zhao W; Zhu J; Huang JF; Xia M
    Zhonghua Wai Ke Za Zhi; 2008 Sep; 46(17):1337-9. PubMed ID: 19094567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of chromosome 1p abnormalities in renal oncocytomas by loss of heterozygosity studies: correlation with conventional cytogenetics and fluorescence in situ hybridization.
    Picken MM; Chyna B; Flanigan RC; Lee JM
    Am J Clin Pathol; 2008 Mar; 129(3):377-82. PubMed ID: 18285259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary collecting system invasion is an independent prognostic factor of organ confined renal cell carcinoma.
    Verhoest G; Avakian R; Bensalah K; Thuret R; Ficarra V; Artibani W; Tostain J; Guille F; Cindolo L; De La Taille A; Abbou CC; Salomon L; Rioux-Leclercq N; Patard JJ
    J Urol; 2009 Sep; 182(3):854-9. PubMed ID: 19616244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early results of bladder-cancer screening in a high-risk population of heavy smokers.
    Steiner H; Bergmeister M; Verdorfer I; Granig T; Mikuz G; Bartsch G; Stoehr B; Brunner A
    BJU Int; 2008 Aug; 102(3):291-6. PubMed ID: 18336612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA.
    Urakami S; Shiina H; Enokida H; Hirata H; Kawamoto K; Kawakami T; Kikuno N; Tanaka Y; Majid S; Nakagawa M; Igawa M; Dahiya R
    Clin Cancer Res; 2006 Dec; 12(23):6989-97. PubMed ID: 17145819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular alterations in atypical adenomatous hyperplasia occurring in benign and cancer-bearing lungs.
    Gradowski JF; Mantha GS; Hunt JL; Dacic S
    Diagn Mol Pathol; 2007 Jun; 16(2):87-90. PubMed ID: 17525677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.